Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Z Mykytyn

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Current Opinion in Virology|August 30, 2023
Antigenic evolution of SARS coronavirus 2Anna Z Mykytyn, Ron Am Fouchier, Bart L Haagmans
Npj Viruses|April 28, 2025
Resistance to SARS-CoV-2 infection in camelid nasal organoids is associated with lack of ACE2 expressionTim I Breugem, Samra Riesebosch, Debby Schipper, et al.
Elife|January 4, 2021
SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage siteAnna Z Mykytyn, Tim I Breugem, Samra Riesebosch, et al.
International Journal for Parasitology|November 3, 2024
Acanthamoeba castellanii trophozoites need oxygen for normal functioning and lipids are their preferred substrate, offering new possibilities for treatmentMaarten J Sarink, Anna Z Mykytyn, Aïsha Jedidi, et al.
Msphere|January 24, 2024
Human metapneumovirus infection of organoid-derived human bronchial epithelium represents cell tropism and cytopathology as observed in <i>in vivo</i> modelsPau Ribó-Molina, Stefan van Nieuwkoop, Anna Z Mykytyn, et al.
One Health Outlook|June 23, 2022
Protective efficacy of an RBD-based Middle East respiratory syndrome coronavirus (MERS-CoV) particle vaccine in llamasJordi Rodon, Anna Z Mykytyn, Guillermo Cantero, et al.
Cell Reports. Medicine|July 20, 2022
Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccineLeonie M Weskamm, Anahita Fathi, Matthijs P Raadsen, et al.
Elife|April 9, 2021
Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptationMart M Lamers, Anna Z Mykytyn, Tim I Breugem, et al.
Mbio|June 13, 2022
Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of ConcernKatharina S Schmitz, Daryl Geers, Rory D de Vries, et al.
Plos Pathogens|August 10, 2023
Glycosylated extracellular mucin domains protect against SARS-CoV-2 infection at the respiratory surfaceMaitrayee Chatterjee, Liane Z X Huang, Anna Z Mykytyn, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Current Opinion in Virology|August 30, 2023
Antigenic evolution of SARS coronavirus 2Anna Z Mykytyn, Ron Am Fouchier, Bart L Haagmans
Npj Viruses|April 28, 2025
Resistance to SARS-CoV-2 infection in camelid nasal organoids is associated with lack of ACE2 expressionTim I Breugem, Samra Riesebosch, Debby Schipper, et al.
Elife|January 4, 2021
SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage siteAnna Z Mykytyn, Tim I Breugem, Samra Riesebosch, et al.
International Journal for Parasitology|November 3, 2024
Acanthamoeba castellanii trophozoites need oxygen for normal functioning and lipids are their preferred substrate, offering new possibilities for treatmentMaarten J Sarink, Anna Z Mykytyn, Aïsha Jedidi, et al.
Msphere|January 24, 2024
Human metapneumovirus infection of organoid-derived human bronchial epithelium represents cell tropism and cytopathology as observed in <i>in vivo</i> modelsPau Ribó-Molina, Stefan van Nieuwkoop, Anna Z Mykytyn, et al.
One Health Outlook|June 23, 2022
Protective efficacy of an RBD-based Middle East respiratory syndrome coronavirus (MERS-CoV) particle vaccine in llamasJordi Rodon, Anna Z Mykytyn, Guillermo Cantero, et al.
Cell Reports. Medicine|July 20, 2022
Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccineLeonie M Weskamm, Anahita Fathi, Matthijs P Raadsen, et al.
Elife|April 9, 2021
Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptationMart M Lamers, Anna Z Mykytyn, Tim I Breugem, et al.
Mbio|June 13, 2022
Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of ConcernKatharina S Schmitz, Daryl Geers, Rory D de Vries, et al.
Plos Pathogens|August 10, 2023
Glycosylated extracellular mucin domains protect against SARS-CoV-2 infection at the respiratory surfaceMaitrayee Chatterjee, Liane Z X Huang, Anna Z Mykytyn, et al.
Pageof 3